Arginine
It is involved in protein synthesis, nitric oxide production, and the urea cycle.
Arginine has been studied for its potential benefits in cardiovascular health, wound healing, and immune function.
Researchers can optimize their arginine-related studies by using the PubCompare.ai tool, which helps identify the most reliable and reproducible protocols from the literature, pre-prints, and patents.
This AI-driven platform provides data-driven insights to enhance the accuracy and efficiency of arginine research.
Most cited protocols related to «Arginine»
We defined a set of three rules based on known properties of the n-, h-, and c-regions. The initial n-region must have a minimum length of two residues and the terminal c-region a minimum length of three residues. The most hydrophobic position, which is identified by sliding a seven-amino-acid window across the SP and computing the hydrophobicity using the Kyte–Doolittle scale29 (link), belongs to the h-region. All positions between these six labeled positions are labeled as either both n and h or h and c, yielding multitag labels.
This procedure was adapted for different SP classes, with only Sec/SPI completely following it. For Tat SPs, the n–h border was identified using the twin-arginine motif. All positions before the motif were labeled n, followed by two dedicated labels for the motif, again followed by a single position labeled n. For SPII SPs, we did not label a c-region, as the C-terminal positions cannot be considered as such30 (link). The last three positions were labeled as the lipobox, all positions before that as h only. For SPIII SPs, no region labels were generated within the SP.
The lDDT score can be computed using all atoms in the prediction (the default choice), but also using only distances between Cα atoms, or between backbone atoms. Interactions between adjacent residues can be excluded by specifying a minimum sequence separation parameter. Unless explicitly specified, the calculation of the lDDT scores for all experiments described in this article has been performed using default parameters, i.e. Ro = 15 Å, using all atoms at zero sequence separation.
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Most recents protocols related to «Arginine»
Example 1
Ultrapure water was taken in a compounding vessel and arginine was added and stirred. Propylene glycol was added to the solution and stirred. pH of the solution was adjusted to 11±0.5 by the addition of sodium hydroxide solution. Then the bulk solution was cooled to 2° C. to 8° C. Levothyroxine sodium was added and stirred till a clear solution was obtained, while maintaining the temperature at 5±3° C. The solution was filtered, followed by filling into suitable containers.
Example 4
Ultrapure water was taken in a compounding vessel and L-Arginine was added and stirred. Propylene glycol was added to the solution and stirred. Methyl paraben was added. pH of the solution was adjusted to 11±0.5 by the addition of sodium hydroxide solution. The solution was cooled to 2° C. to 8° C. Levothyroxine sodium was added and stirred till a clear solution was obtained. The solution was filtered, followed by filling into suitable containers.
Example 5
Ultrapure water was taken in a compounding vessel and L-Arginine was added and stirred. Propylene glycol was added to the solution and stirred. Propyl paraben was added. Sorbitol was added to the solution and stirred. pH of the solution was adjusted to 11±0.5 by the addition of sodium hydroxide solution. The solution was cooled to 2° C. to 8° C. Levothyroxine sodium was added and stirred till a clear solution was obtained. The solution was filtered, followed by filling into suitable containers.
Example 2
Evaluation of 10 mM acetate, 75 mM L-arginine, 2.4% (w/v) sorbitol, 0.01% (w/v) polysorbate 20 excipients formulations and a 10 mM acetate, 5% (w/v) sorbitol, 0.01% (w/v) polysorbate 20 excipients formulation, each with high concentration (120 mg/mL) denosumab, at a temperature of 37° C. for up to 1 month revealed the effects of pH and amino acid aggregation inhibitor on the rate and extent of HMWS formation. The formulations tested are described in Table 2 below. All buffer and excipient values quoted are for the buffer and excipient concentrations that the antibody is diafiltered against.
To prepare test samples M-Q, a 3 mL aliquot of denosumab at 70 mg/mL in acetate, pH 5.2 was dialyzed against 500 mL of DF buffer described below, with a total of 3 buffer changes to achieve a 1 million fold dilution of the previous formulation to ensure complete buffer exchange. The material was then over-concentrated using centrifuge-concentrator, followed by a dilution to 120 mg/mL and the addition of polysorbate 20 to a final concentration of 0.01%.
As the solution pH decreased, there was an increase in formation of large aggregates. At pH below 4.8, and especially 4.5, large aggregates were the dominant HWMS, with a dramatic increase for the test formulation at pH 4.5. As shown in
However, as the pH was increased, there was generally a resulting increase in the dimer species. As shown in
The presence of arginine in formulation O at a concentration of 75 mM resulted in approximately 0.3% and 25% reductions in the amounts of the dimer species and its kinetic rate of formation, respectively, after 1 month at 37° C. when compared to formulation P having the same pH, but without arginine.
Example 9
The compound of Formula 1 (50 mg) was dissolved in MEK (20 vol, 1 ml) at 50° C. To the sample was added 1 mol eq of counterion L-arginine and H2O (5% w/w, 100 μl) The samples were then cooled from 50° C. to 5° C. at a rate of 0.1° C./min. Suspensions were isolated using a filter canular and analysed by XRPD. The material is a crystalline sample (99.0% purity) and the 1H-NMR was consistent with the proposed structure. The TGA analysis showed a 4.68% w/w loss between 30° C. and 100° C., corresponding to 2.1 mol eq of water. The DSC contained endotherm at 75.8° C. (153 J/g), an endotherm at 165.2° C. (41 J/g) and the endothermic melt at 205.9° C. (27 J/g).
Top products related to «Arginine»
More about "Arginine"
It is involved in protein synthesis, nitric oxide production, and the urea cycle.
Arginine has been studied for its potential benefits in cardiovascular health, wound healing, and immune function.
Researchers can optimize their arginine-related studies by using the PubCompare.ai tool, which helps identify the most reliable and reproducible protocols from the literature, pre-prints, and patents.
This AI-driven platform provides data-driven insights to enhance the accuracy and efficiency of arginine research.
Arginine can be supplemented in various forms, including L-arginine and L-lysine, which are commonly used in cell culture media along with other components like fetal bovine serum (FBS), penicillin/streptomycin, and bovine serum albumin (BSA).
These supplements and media components are essential for maintaining cell growth and viability in arginine-related experiments.
By utilizing the PubCompare.ai tool, researchers can access a wealth of information on the most effective and reproducible arginine-related protocols, helping to improve the quality and reliability of their research.
This can lead to a better understanding of arginine's physiological functions and its potential therapeutic applications in areas like cardiovascular health, wound healing, and immune function.